M. Arat Et Al. , "A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).," 47th Annual Meeting of the American-Society-of-Hematology , vol.106, Georgia, United States Of America, 2005
Arat, M. Et Al. 2005. A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).. 47th Annual Meeting of the American-Society-of-Hematology , (Georgia, United States Of America).
Arat, M., Topcuoglu, P., YÜKSEL, M., Dalva, K., Gultekin, G., GÜRMAN, G., ... Arslan, O.(2005). A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114). . 47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America
Arat, M Et Al. "A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).," 47th Annual Meeting of the American-Society-of-Hematology, Georgia, United States Of America, 2005
Arat, M Et Al. "A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).." 47th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America, 2005
Arat, M. Et Al. (2005) . "A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).." 47th Annual Meeting of the American-Society-of-Hematology , Georgia, United States Of America.
@conferencepaper{conferencepaper, author={M Arat Et Al. }, title={A new predictive and prognostic marker for de novo AML: Peripheral blood CD34 (pCD34) count at recovery following remission induction (RI) therapy (Supp. by Ankara university2003-0809114).}, congress name={47th Annual Meeting of the American-Society-of-Hematology}, city={Georgia}, country={United States Of America}, year={2005}}